Loading…
Simultaneous Strontium Doping and Chlorine Surface Passivation Improve Luminescence Intensity and Stability of CsPbI3 Nanocrystals Enabling Efficient Light‐Emitting Devices
A method is proposed to improve the photo/electroluminescence efficiency and stability of CsPbI3 perovskite nanocrystals (NCs) by using SrCl2 as a co‐precursor. The SrCl2 is chosen as the dopant to synthesize the CsPbI3 NCs. Because the ion radius of Sr2+ (1.18 Å) is slightly smaller than that of Pb...
Saved in:
Published in: | Advanced materials (Weinheim) 2018-12, Vol.30 (50), p.e1804691-n/a |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | A method is proposed to improve the photo/electroluminescence efficiency and stability of CsPbI3 perovskite nanocrystals (NCs) by using SrCl2 as a co‐precursor. The SrCl2 is chosen as the dopant to synthesize the CsPbI3 NCs. Because the ion radius of Sr2+ (1.18 Å) is slightly smaller than that of Pb2+ (1.19 Å) ions, divalent Sr2+ cations can partly replace the Pb2+ ions in the lattice structure of perovskite NCs and cause a slight lattice contraction. At the same time, Cl− anions from SrCl2 are able to efficiently passivate surface defect states of CsPbI3 nanocrystals, thus converting nonradiative trap states to radiative states. The simultaneous Sr2+ ion doping and surface Cl− ion passivation result in the enhanced photoluminescence quantum yield (up to 84%), elongated emission lifetime, and improved stability. Sr2+‐doped CsPbI3 NCs are employed to produce light‐emitting devices with a high external quantum yield of 13.5%.
SrCl2 is introduced as a co‐precursor in the synthesis of CsPbI3 perovskite nanocrystals to realize their simultaneous Sr2+ cation doping and surface Cl− anion passivation. The stability of the nanocrystals is improved, and light‐emitting devices with a high external quantum efficiency of 13.5% are realized. |
---|---|
ISSN: | 0935-9648 1521-4095 |
DOI: | 10.1002/adma.201804691 |